Matthias Bodenstedt, Chief Financial Officer at MoonLake Immunotherapeutics, sold MLTX on Jun 18, 2026
Data as of Oct 16
▼ SELL$54.8K2,794 shares at $19.60Matthias Bodenstedt Chief Financial OfficerMLTX MoonLake Immunotherapeutics
- Traded
- Jun 18, 2026
- Disclosed
- Jun 18, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
MLTX since disclosure
−50.3%
after the sale
Similar stocks (XLV) since disclosure
+18.3%
XLV — its sector index fund
Change in closing price from Jun 18, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLMatthias Bodenstedt Chief Financial OfficerMLTX MoonLake Immunotherapeutics$297Kdisclosed Jun 18 · filed 1 day after the trade